Skip to main content
. 2013 Oct 25;23(4):389–397. doi: 10.1017/S2045796013000553

Table 2.

Belief Flexibility and other clinical and demographic variables associated with outcome by Caregiver group (n = 219)

Measure
n (%)
Low EE
(n = 36)
High EE
(n = 20)
Unrated
(n = 24)
BF*** Inflexible 6 (17%) 7 (35%) 9 (38%)
Flexible 30 (83%) 13 (65%) 15 (62%)
Gender Female 8 (22%) 4 (20%) 8 (33%)
Male 28 (78%) 16 (80%) 16 (67%)
Ethnicity* Other 2 (6%) 4 (20%) 7 (29%)
White 34 (94%) 16 (80%) 17 (71%)
Medication level None 1 (3%) 0 0
Low 12 (33%) 5 (25%) 10 (42%)
Medium 14 (39%) 12 (60%) 7 (29%)
High 9 (25%) 3 (15%) 7 (29%)
JTC Yes 20 (80%) 8 (67%) 7 (44%)
No 5 (20%) 4 (33%) 9 (56%)
Mean (s.d.)
Age* (years) 38.5 (12.0) 36.0 (10.5) 33.0 (7.9)
1Length of Illness* (years) 13.2 (11.3) 10.2 (10.0) 6.6 (5.3)
PANSS General 34.9 (5.7) 36.7 (6.8) 33.8 (7.2)
PANSS Negative*** 15.2 (5.0) 15.6 (6.7) 11.9 (4.6)
PANSS Positive* 18.4 (4.4) 20.1 (4.7) 18.2 (4.2)
PANSS Total 68.6 (10.5) 72.5 (14.5) 64.0 (12.0)
1Conviction 3.3 (0.6) 3.2 (0.6) 3.4 (0.6)
Insight mean 2.5 (1.1) 2.8 (1.3) 2.7 (1.3)
2Quick Test IQ 87.7 (17.6) 94.7 (17.5) 94.2 (13.0)
3MARS 2.6 (1.4) 3.0 (1.1) 2.6 (1.4)
GARF*** 63.7 (14.2) 47.7 (13.1) 52.2 (13.5)

n's vary because of non-completion of some measures by participants; 1n's 35,20, 24; 2n's 30, 15, 18; 3n's 34, 19, 23.

KEY: BF = Delusional Belief Flexibility; Medication level (CPZ equivalent) Low = 0–200 mg; Medium = 200–400 mg; High = 400 + mg; JTC = Jumping to conclusions; PANSS = Positive & Negative Syndrome Scale; MARS = Medication Adherence Rating Scale; GARF = Global Assessment of Relational Functioning. *p ≤ 0.05; ***p ≤ 0.001